PROPOFOL
- Product NDC
- 83854-018
- Requested package NDC
- 83854-018-10
- 11-digit product format
- 838540018
- Labeler code
- 83854
- Product ID
- 83854-018_5c98e309-8b86-4513-e063-6294a90aa881
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PROPOFOL
- Dosage form
- INJECTION, EMULSION
- Route
- INTRAVENOUS
- Labeler
- Anthea Pharma Private Limited
- Application
- ANDA220857
- Marketing category
- ANDA
- Marketing start
- 2026-07-14
- Substance
- PROPOFOL
- Active strength
- 10 mg/mL
- Pharmacologic classes
- General Anesthesia [PE], General Anesthetic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220857-001 | PROPOFOL | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | AB | 2026-07-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220857-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220857-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | AB | 2026-07-14 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220857-001 | PROPOFOL | 10MG/ML | INJECTABLE / INJECTION | AB | 2026-07-14 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220857-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220857-001 | AB | 1 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PROPOFOL
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PROPOFOL | 10 mg/mL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PROPOFOL | PROPOFOL | Anthea Pharma Private Limited | f23fe3c5-aa37-4ecc-ad76-f13c1a1dabe2 | 2026-07-15 | Warnings, Adverse reactions | 220857 ANDA220857 83854-018-10 83854-018 83854001810 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 83854-018-10 | 83854001810 | 10 VIAL in 1 CARTON (83854-018-10) / 20 mL in 1 VIAL (83854-018-01) | 10 vial | 2026-07-14 | No | No | Current |